1969
Establishment of Themis Chemicals (now Themis Medicare) in joint partnership with GEDEON Richter Ltd. , Hungary

1971
Themis Chemicals became the Second Company in the world and First Company in India to produce Vitamin B12 by non-sterile fermentation.

1976
Themis Chemicals is the Second Company in the world and FIRST Company in India to produce Ethambutol Dihydrochloride.

1985
Themis Chemicals produces RIFAMPICIN for the FIRST TIME in India

1990
Themis Chemicals develops and produces a unique haemostat – HEMOLOK

1991
Themis Chemicals - produces SISOMICIN and is the ONLY Company other than Schering Plough of USA to master the technology

1991 / 1992
Themis Chemicals develops and introduces ANABLOK^TM (Centbucridine Hydrochloride) – an anaesthetic – along with CDRI, Lucknow – FIRST OF ITS KIND IN THE WORLD.

1993
Themis Chemicals produces GENTAMICIN in India – the only Private Sector Company to do so

1995
Themis Chemicals produces FUMAGILLIN – a unique veterinary product - for the FIRST TIME in the world – exclusive manufacture for French Company

THEMIS CHEMICALS goes Public – listed on the Bombay Stock Exchange

1996
Themis Chemicals produces LOVASTATIN indigenously – FIRST TIME IN INDIA and Third Company in the world to do so

1997
Themis Chemicals bags Ministry of Science and Technology’s Department of Scientific and Industrial Research (DSIR) AWARD for LOVASTATIN

1998
Indigenously develops Simvastatin for the first time in Asia

1999
Launch of E MAL^TM – Alpha Beta Arteether – a THEMIS-CDRI product by the Prime Minister – Shri Atal Behari Vajpayee – Prime Minister of India on Technology Day

Themis Chemicals bags Ministry of Science and Technology’s Department of Scientific and Industrial Research (DSIR) AWARD for development of E MAL^TM – ALPHA BETA ARTEETHER

2001
Themis Chemicals RENAMED – THEMIS MEDICARE LIMITED

2002
Themis Medicare develops and introduces SEPGARD^TM – a unique wound healing agent – FIRST TIME IN INDIA.

2003
Themis Medicare develops and introduces – CLEOFOL^TM – (Lipid free Clear Propofol Injection) – FIRST TIME IN THE WORLD

Themis Medicare develops and introduces – ROFEJET^TM – (Rofecoxib Injection) – the FIRST COX-2 INJECTION in the WORLD

2004
MERGER of Artemis Biotech with Themis Medicare

Themis Medicare establishes SECOND JOINT VENTURE with Gedeon Richter Ltd., Hungary under name – RICHTER THEMIS MEDICARE (INDIA) PVT. LTD. a 100% export oriented unit

2004
Themis Medicare builds new state-of-the-art facility at Hyderabad for Simvastatin Production

2006
Themis Medicare commences operations of its state-of-the-art formulation manufacturing facility at Haridwar.

Themis Medicare develops and introduces NIMESULIDE INJECTION.

THEMISEAL^TM the unique ‘stops bleeding gel’ enters the European market.

Themis Joint Venture Richter Themis Medicare (India) Pvt. Ltd. commences production

Commenced cultivation of Artemisia annua & extraction of Artemisinin.

2007
Themis Medicare develops and introduces ACECLOFENAC INJECTION – FIRST TIME in the world.

Themis Joint Venture – Richter Themis Medicare (India) Pvt. Ltd. has its new API Block ready